Category: Tuberculosis
Global Tuberculosis
-
Global Tuberculosis (TB) Diagnostics Market Analysis and Forecast 2024-2030
... the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those ... Read More
-
Global Tuberculosis (TB) Diagnostics Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
... affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills ... Read More
-
Global Tuberculosis (TB) Diagnostics Market Size, Manufacturers, Opportunities and Forecast to 2030
... other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about ... Read More
-
Live Attenuated Vaccines Market - By Vaccine Type (Bacterial, Viral), Development (Tissue Culture, Embryonated Eggs, Live Animals), Age Group, Mode of Administration, Indication (Tuberculosis, Measles, Rotavirus), End-use - Global Forecast (2024 Â 2032)
... vaccines market will witness 10.4% CAGR from 2024 to 2032. The long-term protection provided by live vaccines against diseases has led to their widespread use besides their ability to stimulate a strong immune response, further ... Read More
-
Infectious Vaccines Market Size, Trends, Analysis, and Outlook By Type (Inactivated Vaccines, Live Attenuated Vaccines, DNA and Recombinant Vector Vaccines, Others), By Disease(Typhoid, Tuberculosis, Tetanus and Diphtheria, Influenza, Hepatitis, Polio, Others), By Distribution Channel (Hospitals, Retail Pharmacies, Online Distribution), by Region, Country, Segment, and Companies, 2024-2030
... Retail Pharmacies, Online Distribution), by Region, Country, Segment, and Companies, 2024-2030 The global Infectious Vaccines market size is poised to register 6.3% growth from 2024 to 2030, presenting significant growth prospects for companies operating in ... Read More
-
Tuberculosis Therapeutics Market Size, Trends, Analysis, and Outlook By Disease (Active TB, Latent TB), By Therapy (First-Line Therapy, Second-Line Therapy), By Route of Administration (Oral, Parenteral, Others), By Dosage Form (Tablets, Capsules, Injection, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030 The global Tuberculosis Therapeutics market size is poised to register 5.24% growth from 2024 to 2030, presenting significant growth prospects ... Read More
-
Computer-Aided Detection Market Size, Trends, Analysis, and Outlook By Application (Tuberculosis, Breast cancer, Lung cancer, Colon/rectal cancer, Prostate cancer, Liver cancer, Bone cancer, Neurological/musculoskeletal/cardiovascular Indications), By Indication (X-ray imaging, Computed tomography, Ultrasound imaging, Magnetic resonance imaging, Nuclear medicing imaging, Others), by Region, Country, Segment, and Companies, 2024-2030
... imaging, Nuclear medicing imaging, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Computer-Aided Detection market size is poised to register 6.57% growth from 2024 to 2030, presenting significant growth prospects for companies operating ... Read More
-
The 2025-2030 World Outlook for Tuberculosis Testing Chest X-Rays
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Tuberculosis Treatment Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Tuberculosis Diagnostics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Tuberculosis Therapeutics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Respiratory Diagnostics for Tuberculosis
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Tuberculosis Testing
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Communicable Diseases
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The Market and Future Potential for Molecular Point-of-Care (mPOC), 11th Edition
... units, physician offices, outpatient clinics, and community health posts, aiming to assess conditions or admit patients accurately. The concept blends the accessibility of point-of-care (POC) testing with the precision of molecular technology. Kalorama Information has ... Read More
-
Lateral Flow Assay Market by Product (Kit, Readers), Application (STI, Covid-19, Hep, TB, Cardiac marker, Pregnancy; Drug abuse, Vet Diaganostic, Food), Sample (Blood, Urine, Saliva), Technique (Sandwich, Competitive), End User - Global Forecast to 2029
... The lateral flow assays market is valued at an estimated USD 10.8 billion in 2023 and is projected treach USD 16.8 billion by 2029, at a CAGR of 7.6% during the forecast period. The rising ... Read More
-
Tuberculosis Diagnostics Test Market - By Test Type (Radiographic, Diagnostic Laboratory, Molecular Diagnostics, Detection of Latent Infection, Cytokine Detection Assay, Detection of Drug Resistance, Phage Assay), End-use - Global Forecast, 2024 - 2032
... Diagnostics Test Market will witness over 5.5% CAGR between 2024 and 2032, spurred by increased availability and efforts to enhance the affordability of these diagnostics. With tuberculosis remaining a global health concern, there is a ... Read More
-
Tuberculosis Drugs Market by Disease (Active TB, Latent TB), Drug Class (Combination Drugs, First-line Anti-TB Drugs, Second-line Anti-TB Drugs) - Global Forecast 2024-2030
... 2023 and expected to reach USD 2.04 billion in 2024, at a CAGR 6.28% to reach USD 2.95 billion by 2030. Global Tuberculosis Drugs Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Zoonotic Disease Treatment Market by Disease Type (Rabies, Tuberculosis, Viral Hepatitis), Drug Class (Antibacterial Medication, Antibiotics) - Global Forecast 2024-2030
... expected to reach USD 42.99 billion in 2024, at a CAGR 5.45% to reach USD 59.18 billion by 2030. Global Zoonotic Disease Treatment Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Tuberculosis Testing Market by Test (Culture Based Tests, Drug Susceptibility Testing, Nucleic Acid Testing), End User (Hospital, Laboratories) - Global Forecast 2024-2030
... and expected to reach USD 2.76 billion in 2024, at a CAGR 7.38% to reach USD 4.23 billion by 2030. Global Tuberculosis Testing Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Tuberculosis Diagnostics Market by Test Type (Drug-susceptibility Testing, Laboratory Methods, Mantoux Test), Type (Point-of-Care Technologies, Rapid Test), End_User - Global Forecast 2024-2030
... and expected to reach USD 3.17 billion in 2024, at a CAGR 5.48% to reach USD 4.38 billion by 2030. Global Tuberculosis Diagnostics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Global Tuberculosis (TB) Diagnostics Market Research Report 2024(Status and Outlook)
... other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about ... Read More
-
Global Tuberculosis Therapeutics Market Research Report 2024(Status and Outlook)
... show no symptoms, in which case it is known as latenttuberculosis. The Global Tuberculosis Therapeutics Market Size was estimated at USD 709.17 million in 2023 and is projected to reach USD 841.86 million by 2029, ... Read More
-
Tuberculosis Diagnostics Market Forecasts to 2030 – Global Analysis By Product Type (Sputum Smear Microscopy, Culture-Based Diagnostics, Rapid Molecular Diagnostics and Other Product Types), Test Type (Detection of Latent Infection, Radiographic Method, Nucleic Acid Testing, Phage Assay, Diagnostic Laboratory Methods, Detection of Drug Resistance, Cytokine Detection Assay and Other Test Types), Disease Stage , End User and By Geography
... Phage Assay, Diagnostic Laboratory Methods, Detection of Drug Resistance, Cytokine Detection Assay and Other Test Types), Disease Stage , End User and By Geography According to Stratistics MRC, the Global Tuberculosis Diagnostics Market is accounted ... Read More
-
Global Nontuberculous Mycobacterial Infections Market 2024-2028
... mycobacterial infections market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
Research Assistance
